Hypera S.A. (OTCMKTS:HYPMY – Get Free Report) passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $3.20 and traded as high as $3.44. Hypera shares last traded at $3.25, with a volume of 2,052 shares changing hands.
Hypera Stock Down 4.7 %
The stock has a 50 day moving average of $3.20 and a 200-day moving average of $3.84. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.81 and a quick ratio of 1.41.
Hypera Company Profile
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Featured Stories
- Five stocks we like better than Hypera
- What is Short Interest? How to Use It
- How to Protect Your Portfolio When Inflation Is Rising
- How to Short Nasdaq: An Easy-to-Follow Guide
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- How to Use the MarketBeat Stock Screener
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
